- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by University Hospital Center of Martinique
Total 39360 results
-
Masonic Cancer Center, University of MinnesotaCompletedGraft vs Host DiseaseUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedJuvenile Myelomonocytic LeukemiaUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedMyelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML)United States
-
University of Michigan Rogel Cancer CenterTerminatedNon-small Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedImproving Quality of Life Using Patient Reported Outcomes Measures Post-operative Via Text MessagingGynecologic CancerUnited States
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingAcute Myeloid Leukemia | Allogeneic Hematopoietic Cell TransplantationUnited States
-
University of Michigan Rogel Cancer CenterCompletedUrothelial CarcinomaUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedCytokine Release Syndrome | Immune and Microbial Reconstitution | Systemic Viral Infection | Acute-graft-versus-host Disease | Chronic Graft-versus-host-disease | Recurrent Malignancy | Allogenic Related Donors | Cell Therapy/Immunotherapy PatientsUnited States
-
Masonic Cancer Center, University of MinnesotaSuspended
-
University of Michigan Rogel Cancer CenterActive, not recruitingProstate CancerUnited States
-
Masonic Cancer Center, University of MinnesotaCompleted
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingFollicular Lymphoma | Acute Myeloid Leukemia | Multiple Myeloma | Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma | Acute Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Plasma Cell Leukemia | Bone Marrow Failure Syndromes | Burkitt's Lymphoma | Acute Lymphoblastic Leukemia... and other conditionsUnited States
-
University of Michigan Rogel Cancer CenterTerminatedChronic Myeloid LeukemiaUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedSarcomaUnited States
-
University of Michigan Rogel Cancer CenterTerminatedGlioma | High Grade Glioma | Pontine TumorsUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedOvarian Cancer | Teratoma | Childhood Germ Cell TumorUnited States
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States
-
University of Michigan Rogel Cancer CenterTerminatedUrothelial CarcinomaUnited States
-
Masonic Cancer Center, University of MinnesotaCompleted
-
Masonic Cancer Center, University of MinnesotaCompleted
-
University of Michigan Rogel Cancer CenterCompleted
-
Masonic Cancer Center, University of MinnesotaCompleted
-
University of Michigan Rogel Cancer CenterCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedRelapsed Acute Myelogenous Leukemia | Refractory Acute Myelogenous LeukemiaUnited States
-
University of Michigan Rogel Cancer CenterWithdrawnLeukemia, Chronic MyeloidUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedGerm Cell TumorUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedFollicular Lymphoma | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Burkitt Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Acute Myelogenous Leukemia | Mantle-Cell Lymphoma | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Small... and other conditionsUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedObesity | Postoperative Complications | Gynecologic NeoplasmsUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedCervical Cancer | Ovarian Cancer | Uterine Endometrial CancerUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedRefractory B-Lineage Leukemia | Relapsed B-Lineage Leukemia | Refractory B-Lineage Lymphoma | Relapsed B-Lineage LymphomaUnited States
-
Masonic Cancer Center, University of MinnesotaCompleted
-
Masonic Cancer Center, University of MinnesotaTerminatedChronic Myelogenous Leukemia | Acute Leukemias | Burkitt's LymphomaUnited States
-
University of Michigan Rogel Cancer CenterCompletedProstate CancerUnited States
-
University of OklahomaStephenson Cancer CenterCompletedBreast NeoplasmsUnited States
-
University of Michigan Rogel Cancer CenterCompletedGenetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance StudyBreast CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminatedHead and Neck NeoplasmsUnited States
-
Masonic Cancer Center, University of MinnesotaCompleted
-
Masonic Cancer Center, University of MinnesotaCompletedMucopolysaccharidosis I | Hurler SyndromeUnited States
-
University of Michigan Rogel Cancer CenterCompletedCarcinoma, Renal CellUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedHurler Syndrome | Mucopolysaccharidosis Type IH | MPS IUnited States
-
University of Michigan Rogel Cancer CenterCompletedPancreatic CancerUnited States
-
Masonic Cancer Center, University of MinnesotaWithdrawn
-
University of Michigan Rogel Cancer CenterCompletedBrain NeoplasmsUnited States
-
University of Michigan Rogel Cancer CenterCompletedOvarian, Fallopian Tube, and Primary Peritoneal CancerUnited States
-
University of Michigan Rogel Cancer CenterWithdrawnCutaneous T Cell LymphomaUnited States
-
University of Michigan Rogel Cancer CenterCompleted
-
Masonic Cancer Center, University of MinnesotaTerminated
-
Masonic Cancer Center, University of MinnesotaCompletedMucopolysaccharidosis I | Mucopolysaccharidosis VI | Mannosidosis | Mucolipidosis Type II (I-cell Disease)United States
-
Masonic Cancer Center, University of MinnesotaCompletedNiemann-Pick Disease | Wolman Disease | Adrenoleukodystrophy | Batten Disease | Metachromatic Leukodystrophy | GM1 Gangliosidosis | Fucosidosis | Globoid Cell Leukodystrophy | Gaucher's Disease | Tay Sachs Disease | Sandhoff DiseaseUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedStage IV MelanomaUnited States